Therapeutic hypothermia in comatose patients with non-shockable initial rhythms may lead to better outcomes
Comatose cardiac arrest patients with non-shockable initial rhythms who are treated with therapeutic hypothermia may have better survival and neurologic outcomes than those who do not receive hypothermic treatment, according ... Using 2000 to 2013 data
45.6%; adjusted OR, 1.11; P<0.001). Utilization of the 3 therapeutic interventions increased during the study period, and these changes were greater in men than women overall
That was significant. There was a shorter time to therapeutic anticoagulation, which we know is important in outcomes,” she said.
The results may appear to conflict with the initial research that motivated guidelines favoring therapeutic hypothermia, but there are a number of important differences, they noted.
They were randomized to either moderate therapeutic hypothermia (33 C during the first 24 hours) or targeted normothermia (37 C). ... The recommendations for managing patients receiving antiplatelets or anticoagulants and for the appropriate use of new
Therapeutic plasma exchange (TPE) was immediately started, and the next day her triglyceride level dropped below 500 mg/dL. ... Therapeutic plasma exchange (TPE) is currently believed to be a safe and effective means of rapidly lowering triglyceride
A systematic review and network meta-analysis compared and ranked therapeutic strategies in adults with moderate to severe acute respiratory distress syndrome (ARDS) to determine which were associated with reduced mortality. ... The goal was to compare
In the current context of rising clinical demands, long waiting lists and shorter appointment times, it's more important than ever to communicate effectively and foster a strong therapeutic relationship. ... Correct inaccurate perceptions and clearly
An accompanying editorial cautioned that longer door-to-furosemide times might have reflected greater diagnostic or therapeutic uncertainty in some cases, making it difficult to draw definitive conclusions. ... An explanation for the difference in
Researchers concluded that there was no benefit of genotype-guided dosing of warfarin on time in the therapeutic INR range during the first month of treatment. ... The researchers noted that the study looked at time in the therapeutic range, rather than